1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Basal activity of PINK1 and PRKN in cell models and rodent brain
(
- Contribution to journal › Article
- 2023
-
Mark
Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals
(
- Contribution to journal › Article
- 2018
-
Mark
Parkin absence accelerates microtubule aging in dopaminergic neurons
(
- Contribution to journal › Article
- 2015
-
Mark
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
(
- Contribution to journal › Article
-
Mark
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
2015) In Neurology(
- Contribution to journal › Article
- 2014
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
- 2013
-
Mark
Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
(
- Contribution to journal › Article
- 2012
-
Mark
Large-scale replication and heterogeneity in Parkinson disease genetic loci
(
- Contribution to journal › Article
- 2011
-
Mark
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
(
- Contribution to journal › Article